Senestech (SNES) Investor presentation summary

Q2 performance

• Q2 2026 revenue reached a record $770K, up 56% QoQ and 23% YoY; gross profit was a record $567K, up 68% QoQ and 39% YoY.

• Gross margin was a record 73.6%, up 510 bps QoQ and 810 bps YoY.

• E-commerce revenue reached a record $511K, up 186% QoQ and 206% YoY; Amazon revenue was a record $349K, up 473% QoQ.

• Subscription revenue was $104K, up 89% QoQ and 142% YoY; subscriptions represented 13.5% of Q2 revenue.

• Q2 net loss was $1.8M and adjusted EBITDA loss was $1.4M; cash and cash equivalents totaled $5.1M at June 30, 2026.

Commercial transformation and growth

• The operating model shifted toward direct e-commerce control, data-driven decisions, professional sales and subscription revenue; Amazon was brought in-house in February 2026.

• E-commerce accounted for 66% of Q2 revenue, versus 26% in Q2 2025; July 2026 e-commerce revenue set a monthly record of $245K.

• B2B priorities include eight verticals with tailored ROI models and case studies; excluding an anomalous Q1 international order, B2B rose 11% sequentially.

• Assessment and monitoring services launched in July 2026, combining field deployment with AI-enabled activity analysis; the first customer deployment was complete.

• The roadmap targets proving the model in 2026, scaling revenue engines in 2027–2028 and establishing category leadership in 2029–2031.

Products and market

• Evolve rat and mouse soft baits and ContraPest liquid bait target rodent fertility and complement traditional integrated pest management.

• ContraPest is described as the first EPA-approved birth control for male and female rats; Evolve is a FIFRA Section 25(b) minimum-risk exempt product.

• The estimated U.S. rodent-control products and services market is $1.8–2.0B; the worldwide market is $4.5B+.

• Market tailwinds include demand for sustainable alternatives, regulatory pushback on poisons and glue traps, rising rodent populations and rodenticide resistance.